Researchers are interested in exploring whether the drug could help nip cancer in the bud at early stages.
Zolgensma, a one-time drug for spinal muscular atrophy, affects 1 in 10,000 children and mostly leads to death.
The acquisition of 100 percent shares of Pola Pharma Inc Japan by the company's wholly owned subsidiary has been concluded, Sun Pharma said in a BSE filing.
GSK Consumer Healthcare says it is considering potential transaction of nutrition business; Unilever confirms development
Hindustan Unilever, the Indian arm of Unilever, confirmed that the company was in the race to acquire GlaxoSmithKline Plc's consumer healthcare nutrition products
GSK started a strategic review of Horlicks - a malt-based drink brand popular in India – and some smaller products, after buying Novartis out of their consumer healthcare venture for $13 billion in March.
GSK to sell Horlicks to fund $13 bn Novartis deal; Nestle, Kraft, Unilever likely suitors, say sources
GSK has started a strategic review of Horlicks - a malt-based drink brand popular in India – and some of its smaller products, after buying Novartis out of their consumer healthcare venture for $13 billion on Tuesday.
Novartis’ new Chief Executive Vas Narasimhan is remaking the Swiss drugmaker’s leadership as operations president Andre Wyss exits
Free diagnostic camps seek to revolutionise healthcare in rural India, but affordability of medicines affecting impact
However, free diagnosis solves only a part of the problem for these villagers.
Over 70 offers were made to ISB students for leadership roles by leading corporates including Aditya Birla Group, Citibank, Yes Bank, Philips India Ltd, Tech Mahindra, MAX, Mytrah Energy and Genpact.
The move shows Google pumping cash into global medical research, seeding what it believes will become a core long-term healthcare business.
Novartis has abandoned a 2016 goal to start testing its autofocus contact lens on people, though it said the groundbreaking product it is making with internet giant Google is "progressing steadily."
These 14 prescription brands acquired by the company earlier this year will be transferred from Novartis Pharma K.K. to Sun Pharma's subsidiary in Japan beginning October 2016
Prices of 56 important drugs used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 percent.
Prices may come down of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, with the government fixing their ceiling prices under the drug pricing control mechanism.
Seeking to create two or three Switzerlands within India, Prime Minister Narendra Modi today courted Swiss business leaders to boost domestic manufacturing and skill development.
The Ahmedabad-headquartered company received a warning letter for its Moraiya formulation facility and Ahmedabad API facility
Natco Pharma has filed new product applications with the US health regulator for generic version of drugs used in the treatment of nervous system disease and cancer.
Cipla, India's fourth-largest generic drugmaker by revenue, had launched its copy of Onbrez in New Delhi in October last year at a fifth of the original drug's price, citing urgent unmet need in India.